(Q34021977)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Ayal Schaffer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Anthony Levitt

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

1 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Psychiatry

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

126-135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

A reevaluation of the exclusion criteria used in antidepressant efficacy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Strengthening clinical effectiveness trials: equipoise-stratified randomization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Sequential treatment of depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

The STAR*D Project results: a comprehensive review of findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

What Are the Implications of the STAR*D Trial for Primary Care? A Review and Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Prevention of relapse following cognitive therapy vs medications in moderate to severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Cost-effectiveness of cognitive-behavioural therapy for mental disorders: implications for public health care funding policy in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

Cognitive therapy vs medications in the treatment of moderate to severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500303

10.1177/070674371005500303

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370962%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference